3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Carcinoma, Non-Small-Cell Lung
17
Carcinoma, Hepatocellular
8
Nasopharyngeal Carcinoma
7
Recurrence
6
Neoplasms
6
Esophageal Neoplasms
6
Breast Neoplasms
6
Stomach Neoplasms
5
Neoplasm Metastasis
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Locally Advanced Rectal Cancer
4
Carcinoma, Renal Cell
4
Urinary Bladder Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Rectal Neoplasms
3
Melanoma
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Hyperthermia
2
Chondrosarcoma
2
Carcinoma, Transitional Cell
2
Interventions
Fluorouracil
13
Cisplatin
7
Radiotherapy
6
Specimen Handling
5
Mitomycin
5
Capecitabine
5
pembrolizumab
4
dehydroftorafur
4
Radiation
4
Drug Therapy
4
Cetuximab
4
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
Biopsy
3
tislelizumab
2
durvalumab
2
aldesleukin
2
VGX-3100
2
Platinum
2
Mitozytrex
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
1,2-diaminocyclohexaneplatinum II citrate
2
toripalimab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
spartalizumab
1
rocakinogene sifuplasmid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Anus Neoplasms
×
Immune Checkpoint Inhibitors
×
Clear all
NCT07555678
2026-04-29
Chase
Fudan University
Phase 2
Recruiting
241 enrolled
NCT04230759
2024-09-19
RADIANCE
Goethe University
Phase 2
Active not recruiting
180 enrolled